Search - tctmd.com

Displaying 61 - 77 of 77

Sort: Relevancy | Date

News Daily News

Renowned Interventionalist Geoffrey O. Hartzler Dies at Age 65

March 15, 2012

News Daily News

Right Coronary CTO Forecasts Mortality After Left Main PCI

Leah Lawrence

March 06, 2012

News Industry News

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

March 06, 2012

News Daily News

Registry Characterizes Prevalence, Management of CTOs Found on Diagnostic Cath

March 05, 2012

News Daily News

Live Case Procedures Just as Safe as in Daily Practice

Caitlin E. Cox

February 21, 2012

News Daily News

Paper Sparks Renewed Discussion on Appropriate Use of PCI

Yael L. Maxwell

February 08, 2012

News Industry News

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

November 07, 2011

News Daily News

Incomplete Revascularization Linked With Mortality in Multivessel Disease Patients

Yael L. Maxwell

October 11, 2011

News Daily News

Meta-analysis: PCI Equivalent to CABG for Many Left Main Patients

September 19, 2011

News Conference News

CABG Favored for Triple Vessel Disease Regardless of Syntax Score

August 29, 2011

News Daily News

CT Perfusion Imaging Captures Anatomy, Function

Caitlin E. Cox

August 24, 2011

News Industry News

Two-Year Follow-Up Data Show Outstanding Clinical Outcomes and Safety for OrbusNeich's GenousTM Stent in Patients at High Risk for Restenosis

August 16, 2011

News Daily News

Endovascular Intervention Generally Safe in Elderly PAD Patients

June 20, 2011

News Daily News

RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES

L.A. McKeown

June 10, 2011

News Daily News

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

May 16, 2011

News Industry News

Positive Long-term Safety and Efficacy Demonstrated for OrbusNeich's GenousTM Stent in Large, Unselected Patient Population with Mostly Complex Lesions and Estimated High Risk for Restenosis

March 28, 2011

News Industry News

Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions

February 14, 2011

Advertisement

Renowned Interventionalist Geoffrey O. Hartzler Dies at Age 65

Right Coronary CTO Forecasts Mortality After Left Main PCI

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

Registry Characterizes Prevalence, Management of CTOs Found on Diagnostic Cath

Live Case Procedures Just as Safe as in Daily Practice

Paper Sparks Renewed Discussion on Appropriate Use of PCI

Three-Year Clinical Outcomes from Use of GenousTM Stent in Large, Real-World Patient Population Demonstrate Long-Term Safety and Efficacy

Incomplete Revascularization Linked With Mortality in Multivessel Disease Patients

Meta-analysis: PCI Equivalent to CABG for Many Left Main Patients

CABG Favored for Triple Vessel Disease Regardless of Syntax Score

CT Perfusion Imaging Captures Anatomy, Function

Two-Year Follow-Up Data Show Outstanding Clinical Outcomes and Safety for OrbusNeich's GenousTM Stent in Patients at High Risk for Restenosis

Endovascular Intervention Generally Safe in Elderly PAD Patients

RESOLUTE All Comers Looks at Simple, Complex Cases in Comparing ZES, EES

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

Positive Long-term Safety and Efficacy Demonstrated for OrbusNeich's GenousTM Stent in Large, Unselected Patient Population with Mostly Complex Lesions and Estimated High Risk for Restenosis

Boston Scientific Acquires Two Novel Technologies to Treat Peripheral Chronic Total Occlusions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content